Mydecine Innovations MYCOF Stock
Mydecine Innovations Price Chart
Mydecine Innovations MYCOF Financial and Trading Overview
| Mydecine Innovations stock price | 0.01 USD |
| Previous Close | 0.19 USD |
| Open | 0.18 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.18 - 0.21 USD |
| 52 Week Range | 0.12 - 1 USD |
| Volume | 16.59K USD |
| Avg. Volume | 36.31K USD |
| Market Cap | 5.53M USD |
| Beta (5Y Monthly) | 3.388028 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.88 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 140 USD |
MYCOF Valuation Measures
| Enterprise Value | 9.44M USD |
| Trailing P/E | N/A |
| Forward P/E | 0.08 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.61 |
Trading Information
Mydecine Innovations Stock Price History
| Beta (5Y Monthly) | 3.388028 |
| 52-Week Change | -70.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1 USD |
| 52 Week Low | 0.12 USD |
| 50-Day Moving Average | 0.31 USD |
| 200-Day Moving Average | 0.43 USD |
MYCOF Share Statistics
| Avg. Volume (3 month) | 36.31K USD |
| Avg. Daily Volume (10-Days) | 10.07K USD |
| Shares Outstanding | 24.94M |
| Float | 24.06M |
| Short Ratio | N/A |
| % Held by Insiders | 5.58% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:45 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -261.055% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -15487333 USD |
| Net Income Avi to Common (ttm) | -19258032 USD |
| Diluted EPS (ttm) | -0.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 565.71K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 5.02M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.329 |
| Book Value Per Share (mrq) | -0.374 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9807123 USD |
| Levered Free Cash Flow (ttm) | -7216609 USD |
Profile of Mydecine Innovations
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 789 West Pender Street |
| ZIP | V6C 1H2 |
| Phone | 720-277-9879 |
| Website | https://www.mydecine.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Q&A For Mydecine Innovations Stock
What is a current MYCOF stock price?
Mydecine Innovations MYCOF stock price today per share is 0.01 USD.
How to purchase Mydecine Innovations stock?
You can buy MYCOF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mydecine Innovations?
The stock symbol or ticker of Mydecine Innovations is MYCOF.
Which industry does the Mydecine Innovations company belong to?
The Mydecine Innovations industry is Drug Manufacturers-Specialty & Generic.
How many shares does Mydecine Innovations have in circulation?
The max supply of Mydecine Innovations shares is 52.57M.
What is Mydecine Innovations Price to Earnings Ratio (PE Ratio)?
Mydecine Innovations PE Ratio is now.
What was Mydecine Innovations earnings per share over the trailing 12 months (TTM)?
Mydecine Innovations EPS is -0.88 USD over the trailing 12 months.
Which sector does the Mydecine Innovations company belong to?
The Mydecine Innovations sector is Healthcare.